Daewoong Pharmaceutical Revolutionizes Drug Development with AI System

🔬 Daewoong's AI system accelerates breakthroughs in obesity, diabetes, and cancer drug development.

 19 February 2024

Insilico Medicine's AI-Designed Drug for Inflammatory Bowel Disease Enters Phase I Trials

🧬 Insilico Medicine's AI-crafted IBD drug starts human trials.

 28 January 2024

Insilico Medicine: Revolutionizing Drug Development with AI-Designed Drug

Insilico Medicine: Revolutionizing Drug Development with AI-Designed Drug

 24 November 2023